the aid library

Filter

8653

Birth defects surveillance training: facilitator's guide

World Health Organization (WHO), National Center on Birth Defects and Developmental Disabilities from the United States Centers for Disease Control and Prevention (CDC), International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) (2015) C_WHO

The goal of this course is to provide participants with the foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomalies surveillance programme, in particular for countries with limited resources. It focuses on the methodology needed to devel ... more

Philippine Health Advisories

Department of Health, National Center for Health Promotion, National Center for Disease Prevention and Control (2012) C1

WHO/Europe and ECDC Monkeypox Surveillance Bulletin
recommended

World Health Organization WHO, Regional Office of Europe; European Center for Disease Control ECDC (2022) C_WHO

Here you can find the latest reports

Multiple Indicator Cluster Survey (2016-17)

National Bureau of Statistics (NBS), National Primary Health Care Development Agency (NPHCDA) and National Agency for the Control of Aids (NACA) (2017) C1

Survey finding report

Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care

F. Biadglegne, U. Sack, A. C. Rodloff (2014) C1

Antimicrobial Resistance and Infection Control 2014,3 :31

Revised Schemes for NGOs and Private Providers - 2008

National Rural Health Mission, DOTS (2008)

Revised National Tuberculosis Control Programme

TB in India 2017
recommended

Central TB Divison, Ministry of Health and Social Welfare, Government of India World Health Organisation (WHO) (2017) C1

Revised National TB Control Programme. Annual Status Report

Uganda: Algorithm for TB Screening, Diagnosis and Management

Ministry of Health, Republic of Uganda (2017) C1

National Tuberculosis and Leprosy control Program

The National Tuberculosis Health Sector Strategic Plan 2015-2020
recommended

Bonsu FA, Hanson-Nortey NN, Afutu FK et al. Ghana, Ministry of Health (2014) C1

The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National T ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for h ... ospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Manual for Parasitological Surveillance in Prevention of Re-introduction/Re-establishment of Malaria in Sri Lanka

Anti-Malaria Campaign (AMC), Sri Lanka Ministry of Health, Sri Lanka (2019) C2

The Manual for Parasitological Surveillance in Prevention of Reintroduction or Re-establishment of Malaria in Sri Lanka (2019) provides guidelines to health professionals on how to conduct effective malaria surveillance to prevent the reintroduction ... more

National Malaria Elimination Strategic Plan (NMESP) 2024–2028

National Malaria Elimination Programme (NMEP) Ghana Health Service - Ministry of Health, Ghana (2023) C2

The National Malaria Elimination Strategic Plan (NMESP) 2024–2028 of Ghana outlines the country’s roadmap to shift from malaria control to elimination. Despite major progress—like reducing malaria deaths from nearly 2,800 in 2012 to 151 in 202 ... more

Review of the National Tuberculosis Programme: Myanmar, 7-15 November 2011

World Health Organization (WHO) (2012) C_WHO

Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review ... more

National Tuberculosis, Leprosy and Lung Disease Orogram Tuberculosis (TB) Isolation Policy

Ministry of Health, Kenya (2018) C1

Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectio ... more

Limited Access Humanitarian Programming

Sandisan, P. Oxfam (2017) C1

Operational guidance for managing programme quality. These guidelines are about implementing the programme-quality standards of the Core Humanitarian Standard in limited access humanitarian response. They have been developed using approaches and to ... more

Literature Review on Tuberculosis in Prisons

World Health Organization (2008) C_WHO

Literature Review on TB Control in Prisons 11/18/2008

Rencana aksi nasional: Programmatic Management of Drug Resistance Tuberculosis, Pengendalian Tuberkulosis Indonesia 2011-2014

Kementerian Kesehatan Republik Indonesia (2011) C1

National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia

Kenya National Cancer Treatment Protocols

Ministry of Health, Kenya Ministry of health (2019) C1

The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint ... more

Mozambique Operational Plan (COP/ROP) 2017 Strategic Direction Summary

PEPFAR (2017) C1

The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress ... more

WHO best practices for injections and related procedures toolkit

World Health Organization; SIGN (2010) C_WHO

The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.